46. Alter, H. S. “Baruch Blumberg.” Nature 473 (2011): 155.
47. Sutnick, A. I., W. T. London, B. J. S. Gerstley, M. M. Cronlund, and B. S. Blumberg. “Anicteric Hepatitis Associated with Australia Antigen. Occurrence in Patients with Down’s Syndrome.” Journal of the American Medical Association 205 (1968): 670–74.
48. Prince, A. M. “An Antigen Detected in Blood During Incubation Period of Serum Hepatitis.” Proceedings of the National Academy of Sciences USA 60 (1968): 814–21.
49. London, W. T., A. I. Sutnick, and B. S. Blumberg. “Australia Antigen and Acute Viral Hepatitis.” Annals of Internal Medicine 70 (1969): 55–59.
50. Prince, A. M., R. L. Hargrove, W. Szmuness, C. E. Cherubin, V. J. Fontana, and M. B. Jeffries. “Immunologic Distinction Between Infectious and Serum Hepatitis.” New England Journal of Medicine 282 (1970): 282–87.
51. Walsh, J. H., R. H. Purcell, A. G. Morrow, R. M. Chanock, and P. J. Schmidt. “Posttransfusion Hepatitis after Open-Heart Operations. Incidence after the Administration of Blood from Commercial and Volunteer Donor Populations.” Journal of the American Medical Association 211 (1970): 261–65.
52. Alter, H. J., P. V. Holland, R. H. Purcell, J. J. Lander, S. M. Feinstone, A. G. Morrow, and P. J. Schmidt. “Posttransfusion Hepatitis after Exclusion of the Commercial and Hepatitis B Antigen Positive Donor.” Annals of Internal Medicine 77 (1972): 691–99.
53. Feinstone, S. M., A. Z. Kapikian, R. H. Purcell, H. J. Alter, and P. V. Holland. “Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B.” New England Journal of Medicine 292 (1975): 767–70.
54. Alter, H. J., R. H. Purcell, P. V. Holland, and H. Popper. “Transmissible Agent in ‘Non-A, Non-B’ Hepatitis.” Lancet 1 (1978): 463–65.
55. Tabor, E., R. J. Gerety, J. A. Drucker, L. B. Seeff, J. H. Hoofnagle, D. R. Jackson, M. April, L. F. Barker, and G. Pineda-Tamondong. “Transmission of Non-A, Non-B Hepatitis from Man to Chimpanzee.” Lancet 1 (1978): 466–68.
56. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. “Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome.” Science 244 (1989): 359–62.
57. Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. “Robust Hepatitis C Virus Infection In Vitro.” Proceedings of the National Academy of Sciences USA 102 (2005): 9294–99.
58. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, et al. “Complete Replication of Hepatitis C Virus in Cell Culture.” Science 309 (2005): 623–26.
59. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, et al. “Production of Infectious Hepatitis C Virus in Tissue Culture from a Cloned Viral Genome.” Nature Medicine 11 (2005): 791–96.
60. Shlomai, A., and C. M. Rice. “Getting Rid of a Persistent Troublemaker to Cure Hepatitis.” Science 343 (2014): 1212–13.
Глава 9. Общий обзор только что появившихся вирусных эпидемий: геморрагических лихорадок. Новый таинственный вирусный подозреваемый – острый вялотекущий паралич
1. LeGuenno, B. “Emerging Viruses.” Scientific American 273 (October 1995): 56–64.
2. McNeill, W. H. Plagues and Peoples. New York: Anchor Books, 1976.
3. Riviere, Y., and M. B. A. Oldstone. “Genetic Reassortants of Lymphocytic Choriomeningitis Virus: Unexpected Disease and Mechanism of Pathogenesis.” Journal of Virology 59 (1986): 363–68.
4. Oldstone, M. B. A., M. Salvato, A. Tishon, and H. Lewicki. “Virus – Lymphocyte Interactions. III. Biologic Parameters of a Virus Variant That Fails to Generate CTL and Establishes Persistent Infection in Immunocompetent hosts.” Virology 164 (1988): 507–16.
5. Scholtissek, C., A. Vallbracht, B. Flehmig, and R. Rott. “Correlation of Pathogenicity and Gene Constellation of Influenza A Virus. II. Highly Neurovirulent Recombinants Derived from Non-Virulent or Weakly Neurovirulent Parent Virus Strains.” Virology 95 (1979): 492–98.
6. Rubin, D. H., and B. N. Fields. “Molecular Basis of Reovirus Virulence. Role of the M2 gene.” Journal of Experimental Medicine 152 (1980): 853–57.
7. Knipe, D., and P. Howley, eds. Fields Virology, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2007.
8. Leroy, E. M., B. Kumulungui, X. Pourrut, P. Rouquet, A. Hassanin, P. Yaba, A. Delicat, J. T. Paweska, J. P. Gonzalez, and R. Swanepoel. “Fruit Bats as Reservoirs of Ebola Virus.” Nature 438 (2005): 575–76.
9. Goldstein, T., S. J. Anthony, A. Gbakima, B. H. Bird, J. Bangura, A. Tremeau-Bravard, M. N. Belaganahalli, et al. “The Discovery of Bombali Virus Adds Further Support for Bats as Hosts of Ebolaviruses.” Nature Microbiology 3 (2018): 1084–89.
10. Messacar, K., T. L. Schreiner, K. Van Haren, M. Yang, C. A. Glaser, K. L. Tyler, and S. R. Dominguez. “Acute Flaccid Myelitis: A Clinical Review of US Cases 2012–2015.” Annals of Neurology 80 (2016): 326–38.
11. Ayscue, R., K. Van Haren, H. Sheriff, E. Waubant, P. Waldron, S. Yagi, C. Yen, et al.; Centers for Disease Control and Prevention (CDC). “Acute Flaccid Paralysis with Anterior Myelitis – California, June 2012–June 2014.” MMWR Morbidity and Mortality Weekly Report 63 (2014): 903–6.
12. Pastula, D. M., N. Aliabadi, A. K. Haynes, K. Messacar, T. Schreiner, J. Maloney, S. R. Dominguez, et al.; Centers for Disease Control and Prevention (CDC). “Acute Neurologic Illness of Unknown Etiology in Children – Colorado, August – September 2014.” MMWR Morbidity and Mortality Weekly Report 63 (2014): 901–2.
13. Division of Viral Diseases, National Centers for Immunization and Respiratory Diseases, CDC; Division of Vector-Borne Diseases, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC; Children’s Hospital Colorado; Council of State and Territorial Epidemiologists. “Notes from the Field: Acute Flaccid Myelitis among Persons Aged <21 Years – United States, August 1–November 13, 2014.” MMWR Morbidity and Mortality Weekly Report 63 (2015): 1243–44.
14. Centers for Disease Control and Prevention. “Investigation of Acute Neurologic Illness with Focal Limb Weakness of Unknown Etiology in Children, Fall 2014, 2015.”
15. Vogel, G. “Outbreaks of Poliolike Disease Pose a Puzzle.” Science 362 (2018): 277.
16. Messacar, K., E. J. Asturias, A. M. Hixon, C. Van Leer-Buter, H. G. M. Niesters, K. L. Tyler, M. J. Abzug, and S. R. Dominguez. “Enterovirus D68 and Acute Flaccid Myelitis – Evaluating the Evidence for Causality.” Lancet Infectious Diseases 18 (2018): e239–47.
17. Midgley, C. M., J. T. Watson, W. A. Nix, et al. “Severe Respiratory Illness Associated with a Nationwide Outbreak of Enterovirus D68 in the USA (2014): A Descriptive Epidemiological Investigation.” Lancet Respiratory Medicine 3 (2015): 879–87.
18. Centers for Disease Control and Prevention. “Enterovirus D68, 2017.” https://www.cdc.gov/non-polio-enterovirusabout/ev-d68.html.
19. Wang, G., J. Zhuge, W. Huang, S. M. Nolan, V. L. Gilrane, C. Yin, N. Dimitrova, and J. T. Fallon. “Enterovirus D68 Subclade B3 Strain Circulating and Causing an Outbreak in the United States in 2016.” Scientific Reports 7 (2017): 1242.
20. Gander, K. “Acute Flaccid Myelitis Symptoms: Polio-like Condition Can Cause Paralysis Overnight.” Newsweek, October 26, 2018.
21. Reddy, S. “A New Burst of Polio-like Cases Alarms Doctors.” Wall Street Journal, November 6, 2018.
22. Ollove, M. “Polio-like Illness AFM Tests an Overstretched Public Health System.” Huffingtonpost, November 15, 2018.
Глава 10. Лихорадка Ласса
1. McCormick, J. B. “Arenaviruses.” In Fields Virology, edited by B. N. Fields, 1245. New York: Raven Press, 1990.
2. Frame, J. D., J. M. Badwin Jr., D. J. Gocke, and J. M. Troup. “Lassa Fever, a New Virus Disease of Man from West Africa.” American Journal of Tropical Medicine and Hygiene 19 (1970): 670–76.
3. Frame, J. D. “The Story of Lassa Fever. Part I: Discovering the Disease.” New York State Journal of Medicine 92 (1992): 199–202.
4. Frame, J. D. “The Story of Lassa Fever. Part II: Learning More About the Disease.” New York State Journal of Medicine 92 (1992): 264–67.
5. Cao, W., M. D. Henry, P. Borrow, H. Yamada, J. H. Elder, E. V. Ravkov, S. T. Nichol, R. W. Compans, K. P. Campbell, and M. B. Oldstone. “Identification of Alpha-Dystroglycan as a Receptor for Lymphocytic Choriomeningitis Virus and Lassa Fever Virus.” Science 282 (1998): 2079–81.
6. Sevilla, N., S. Kunz, A. Holz, H. Lewicki, D. Homann, H. Yamada, K. P. Campbell, J. C. de la Torre, and M. B. Oldstone. “Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells.” Journal of Experimental Medicine 192 (2000): 1249–60.
7. Kunz, S., N. Sevilla, D. B. McGavern, K. P. Campbell, and M. B. Oldstone. “Molecular Analysis of the Interaction of LCMV with Its Cellular Receptor (Alpha)-Dystroglycan.” Journal of Cell Biology 155 (2001): 301–10.
8. Zuniga, E. I., L. – Y. Liou, L. Mack, M. Mendoza, and M. B. A. Oldstone. “Persistent Virus Infection Inhibits Type I Interferon Production by Plasmacytoid Dendritic Cells to Facilitate Opportunistic Infections.” Cell Host & Microbe 4 (2008): 374–86.
9. Kunz, S., J. M. Rojek, M. Kanagawa, C. F. Spiropoulou, R. Barresi, K. P. Campbell, and M. B. Oldstone. “Posttranslational Modification of Alpha-Dystroglycan, the Cellular Receptor for Arenaviruses, by the Glycosyltransferase LARGE Is Critical for Virus Binding.”